Loading
No insider purchase over the last 90 days. The latest was filed 21 Nov 2024.
INNOVATE Corp.: what insiders have been doing
INNOVATE Corp. belongs to the Industry sector. Filings by its managers are published through SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for INNOVATE Corp. logged 8 filings by 6 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
No insider has bought INNOVATE Corp. shares on the open market in the past twelve months. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction.
With 8 filings in twelve months, the company is quieter than the median of 22 filings across the 5,458 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 19 purchases and 4 sales. The 10-K for the year ended 31 December 2025 shows 1.25 bn USD of revenue and -60.6 m USD of net income.
In the same sector, recent insider purchases at Tennant Co and Butler National Corp also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
73
Thresholds
n/a
Buy Volume
€1M
19 ops. · all time
Sell Volume
€136,314
4 ops. · all time
Who traded when
BuySalePaul Voigt1 buy
Since the insiders bought
- -14.4%Entry US$5.99 · Close at T+365 US$5.13
- -48.9%Entry US$13.50 · Close at T+365 US$6.90
- -19.0%Entry US$24.80 · Close at T+365 US$20.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22,745 of 24,161 companies
17.2
score / 100
Value21
Quality14
FCF yld·
Earn yld-78%
EV/EBITDA13.8x
ROE·
Gross mgn16%
Net mgn-5.1%
Debt/EBITDA12.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$6.00
Analyst consensus
Income statement
RevenueUS$1.2B
Gross profitUS$199.7M16% margin
EBITDAUS$57.9M5% margin
Net income-US$64M-1.5% margin
Valuation
Beta2.45
Balance sheet & cash
Market capUS$81.9M
Total debtUS$717.5M
Free Cash FlowUS$120.5M
Profitability & ownership
ROA4.3%
% insiders62.5%
% institutions23.2%
Last declaration on 13 August 2026
Declarations73 total
133,511 shares0Common StockSEC:0001006837-26-000087:0
60,643 shares@ US$7.62090.43% mcap23.0% of flowCommon StockSEC:0001006837-26-000087:1
12,016 shares0Common StockSEC:0001006837-26-000086:0
12,016 shares0Common StockSEC:0001006837-26-000083:0
12,016 shares0Common StockSEC:0001006837-26-000085:0
12,016 shares0Common StockSEC:0001006837-26-000084:0
15,576 shares0Common StockSEC:0001006837-26-000088:0
1,784 shares@ US$4.354.6% of flowCommon StockSEC:0001562966-26-000002:0
176,056 shares@ US$5.6849.1% of flowCommon StockSEC:0001621020-25-000005:0
16,363 shares0Common StockSEC:0001006837-25-000072:0
16,363 shares0Common StockSEC:0001006837-25-000071:0
16,363 shares0Common StockSEC:0001006837-25-000070:0
16,363 shares0Common StockSEC:0001006837-25-000073:0
4,302 shares@ US$7.6620.8% of flowCommon StockSEC:0001006837-25-000011:0
862 shares@ US$7.233.9% of flowCommon StockSEC:0001006837-25-000009:0
2,097,902 shares0Common StockSEC:0001006837-24-000166:0
25,000 shares@ US$3.985.4% of flowCommon StockSEC:0001006837-24-000164:0
Canonical exit: 17 Feb 2025 (T+90)
95,322 shares0Common StockSEC:0001006837-24-000144:0
43,785 shares@ US$3.808.6% of flowCommon StockSEC:0001006837-24-000133:0
Canonical exit: 11 Dec 2024 (T+90)
161,001 shares0Common StockSEC:0001006837-24-000105:0
161,001 shares0Common StockSEC:0001006837-24-000106:0
161,001 shares0Common StockSEC:0001006837-24-000104:0
161,001 shares0Common StockSEC:0001006837-24-000107:0
176 shares@ US$0.600.0% of flowCommon StockSEC:0001006837-24-000095:0
Canonical exit: 12 Sept 2024 (T+90)
1,965 shares@ US$0.600.1% of flowCommon StockSEC:0001006837-24-000085:0
Canonical exit: 8 Sept 2024 (T+90)
25 of 73 declarations
About INNOVATE Corp.
INNOVATE Corp. is a United States-based company listed on the NYSE under the ticker VATE, with its principal executive offices in New York, New York. The company was incorporated in 1994 and operates as a diversified holding company rather than a pure-play industrial manufacturer. For investors, the key point is that INNOVATE should be viewed as a special-situations holding structure: equity value is driven not only by operating performance at the subsidiary level, but also by leverage, refinancing capacity, and asset portfolio decisions. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001006837/000100683726000014/vate-20251231.htm))
The largest and most important operating platform is Infrastructure, centered on DBM Global Inc. DBM Global is a fully integrated construction company providing construction and professional services through businesses such as Schuff Steel Company, Banker Steel, and GrayWolf Industrial. These operations serve a broad mix of commercial and industrial end markets, with a core focus on structural steel and specialized construction work. This segment is the main revenue engine of the group and ties INNOVATE closely to the U.S. industrial construction cycle. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001006837/000100683726000014/vate-20251231.htm))
Read moreShow less
INNOVATE also maintains a Life Sciences platform through Pansend Life Sciences, LLC, which is focused on healthcare and biotechnology product development. One of the more visible portfolio companies is R2 Technologies, headquartered in Dublin, California. R2 develops aesthetic medical and non-medical devices built around its CryoAesthetics™ technologies and Glacial® platform, which use precision cooling to improve skin tone and reduce inflammation and discoloration. Founded in 2014, R2 has brought products such as Glacial Rx, Glacial Spa, and Glacial fx into commercialization across multiple geographies. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001006837/000100683726000014/vate-20251231.htm))
A smaller Spectrum segment remains part of the portfolio, historically linked to broadcasting/media-related assets. Even so, the overall corporate profile is clearly weighted toward industrial construction and, to a lesser extent, medtech and other non-core assets. INNOVATE itself states that it is a holding company whose principal source of cash comes from distributions from its subsidiaries. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001006837/000100683726000014/vate-20251231.htm))
From a competitive standpoint, INNOVATE is not a large-cap diversified industrial leader. Instead, it operates as a niche, asset-backed group in fragmented and competitive markets. DBM Global’s technical capabilities and project execution are potential strengths, while the Life Sciences portfolio offers some longer-dated optionality. Against that, the company’s financial structure is a central consideration: debt maturities, covenant pressure, and potential divestitures remain material strategic variables. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001006837/000100683726000014/vate-20251231.htm))
Recent filings and disclosures show that the company released its full-year 2025 results on March 26, 2026 and its first-quarter 2026 results on May 14, 2026. Those filings also highlight ongoing liquidity stress and capital-structure management as major themes for the year ahead. For French-speaking investors, VATE is best understood as an NYSE-listed U.S. holding company where operational execution, asset monetization, and balance-sheet repair are tightly linked. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001006837/000100683726000013/vate-20260326.htm))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
